Medicenna Therapeutics Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medicenna Therapeutics Corp. generated cash of -$16,260,000, which is less than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore -$16,614,000.
Cash Flow
| 2016 | -2.57M | 0 | 7.85M |
|---|---|---|---|
| 2018 | -10.12M | -140.02K | 469.39K |
| 2020 | -8.95M | -15M | 44.28M |
| 2021 | -15.31M | 5.01M | 18.25M |
| 2023 | -12.65M | -13.04M | 24.76M |
| 2024 | -16.26M | 0 | 0 |
MDNA.TO Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 33.59M | 20.53M | 22.69M | 2.37M | 14.03M | 125.56K |
Operating activities | ||||||
Net income | -25.46M | -10.04M | -17.28M | -8.27M | -7.46M | -1.33M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 4K | 4K | 40K | 7.89K | 9.70K | 1.43K |
Stock-based compensation expense | 1.20M | 1.37M | 1.00M | 1.12M | 1.61M | 0 |
| Deferred income tax benefit | 1.20M | 1.37M | 1.00M | 1.12M | 1.61M | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 1.67M | 1.23K | -1.61K | 139 | -439 | -210.77K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 451.87K | 313.67K |
Cash generated by operating activities | -16.26M | -12.65M | -15.31M | -8.95M | -10.12M | -2.57M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | -10M | -15M | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -13.04M | 5.01M | -15M | -140.02K | 0 |
Financing activities | ||||||
Common Stock Issued | 0 | 24.76M | 11.41M | 38.37M | 469.39K | 3.32M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -40 |
Repayments of term debt | 0 | 0 | -39K | 0 | 0 | 0 |
Cash used in financing activities | 0 | 24.76M | 18.25M | 44.28M | 469.39K | 7.85M |
Net Change In Cash | -16.61M | 13.06M | 7.67M | 20.32M | -10.09M | 5.21M |
Cash at end of period | 16.98M | 33.59M | 30.37M | 22.69M | 3.93M | 5.33M |
| Data source | Data source | Data source | Data source | Data source | Data source |